Notal Vision
Latest round
- Series D
Last raised
- Jun 2021
Total raised
- $60M
Investors
- 4
About Notal Vision
Based in the US, Notal Vision, Inc.Notal Vision, Inc. was founded in 2000 and is headquartered in Manassas, US. The company specializes in the development of diagnostic technologies aimed at improving the management of AMD. The founders include Axelle Alibert and Barak Azmon, with Axelle Alibert currently serving as CEO.Notal Vision specializes in innovative digital health solutions targeting the management of age-related macular degeneration (AMD) through home-based monitoring technologies. The company's core product, ForeseeHome®, serves as an early warning system, enabling physicians to diagnose wet AMD earlier and improve long-term visual outcomes for patients. This system facilitates real-time patient monitoring and provides automated analysis of home-based optical coherence tomography (OCT) images through the proprietary Notal OCT Analyzer. Additionally, Notal Vision's diagnostic devices empower patients to conduct tests from home, thereby extending eye disease management beyond the traditional clinical setting and catering to both physicians and patients.S.Notal Vision generates revenue through direct transactions for its diagnostic products and services, primarily via subscription models that facilitate ongoing patient monitoring and data analysis. Physicians and healthcare practices implement the ForeseeHome® system to enhance patient care, ultimately leading to consistent revenue flow as they utilize the technology for managing AMD. The pricing structure for their offerings includes the provision of home-based diagnostic devices and continuous access to the AI-driven analysis platform, which streamlines the diagnostic process for eye care professionals. By fostering partnerships with healthcare providers, Notal Vision ensures integration of its products into existing treatment paradigms, reinforcing its market position. The company is working on upcoming innovations in its diagnostic product line, with specific release dates to be announced. Additionally, Notal Vision aims to target expansion into European markets by 2025 and strengthen its presence in regions experiencing a rising prevalence of AMD.
Who invested in Notal Vision
4 investors across 1 round
See all investors in Notal Vision
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jun 1, 2021
Amount
$60M
Investors
Questions about Notal Vision
Who invested in Notal Vision?
Notal Vision has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Notal Vision raised?
Notal Vision has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Notal Vision last raise money?
Notal Vision's most recent round on record is a Series D, in Jun 2021.
What does Notal Vision do?
Based in the US, Notal Vision, Inc.
Where is Notal Vision headquartered?
Notal Vision is headquartered in Manassas, US.
Which VCs invest in companies like Notal Vision?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Notal Vision's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Notal Vision? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.